CMPS

PlantAstronaut

CMPS, ATAI, PSIL Psychedelic medicines are a long way off, but I hope to retire on these guys alone. Dirt cheap right now.

CultureForsaken3762

Went to Afterlife in Miami yesterday. Massive music festival. EVERYONE is on psychedelics of some kind. This industry will eventually generate tens of billions of dollars per year in revenue and the top publicly traded companies in the space currently are sub-$1 billion in market cap. MNMD, ATAI, CYBN, CMPS much more room to run. They are cheap call options with no expiration.

likwid07

Any thoughts on how long it'll take for CMPS to be on the market? Seems like it's a game of chicken between government approval and their solvency.

__Evil-Genius__

Well, you’re onto one of the best ones already. CMPS and MNMD are the two top contenders in my estimation. PBM and CYBN are my other two holdings. Both have begun their ascent in the past month. Compass will probably be first to market though, so keep that in mind.

noonesnotnone

CMPS

CultureForsaken3762

Shroom Boom is back. Clinical trials across the sector are showing positive momentum. MNMD, CYBN, CMPS, ATAI

antjamesvir

Looks good to me! I took a quick look and will do some more research on it later tonight. The only other stock i hold currently is 50 NVDA shares with a $600 cost basis. I have indeed been searching for a new promising stock in the $8-15 range, I have looked extensively into ALT and CMPS to possibly be the next viking, they have some some positive things going for them, but also some negatives. HIMS is another one I have been looking into quite a bit for a rapid growth stock, but I don't find the company interesting at all. I am having a very hard time committing to anything else right now other than viking or nvda cause they have performed so incredibly well for me.

CultureForsaken3762

The #ShroomBoom is happening and its still early. This something Republicans and Democrats both support from a medicinal perspective. Silicon Valley Libs love it. War veterans in the South love it. $CYBN $MNMD $ATAI $CMPS

lipmanz

Is CMPS drug legal?

variablestonkflip

$CMPS easy biomed play

LawlessSapien

CMPS for shroom

No_Cantaloupe8848

$CMPS- phase 3 results by the end of year. Psychedelics as medicine will be huge

lipmanz

Is CMPS actually going to happen?

Mindmed2022

You should buy MNMD and CMPS if you enjoyed the shrooms. 🍄

AngryWeedle

Go CMPS :)

AngryWeedle

CMPS then :)

AngryWeedle

Just do CMPS. It'll be fun.

VoiceAlly

I've been buying SATS, PARA, NTLA, DNA, CMPS, MSOS and VFF. Also movie stock.

No_Cantaloupe8848

Anyone watching price action on $CMPS.

Astroneutre

With the announcement of FDA approval by the end of the week we risk seeing companies like CMPS, ATAI and CYBN gain a few points. I heard that the PSKY ETF will be delisted in April.

VoiceAlly

I'm invested in MSOS, DNA, SATS, PARA, NTLA, CMPS, PYPL, PLTR, AMC. I obviously think they will sail and many haven't yet for me.

newwerraa

$NUMI is the play, Rick Doblin of maps even said he will be sending thousands of therapists to Numinus for training. Then as of Friday they’ve officially invested in NUMI through a bought deal. They’ve brought their burn down significantly and already have clinics operating on the grounds. Their tie with MAPS is a huge sell here and they plan on being profitable before MDMA -AT is approved. I doubled my position last week and Friday they had their most volume traded in years. They have many connections in the industry and host trials for many of the big dogs like MMED and CMPS.

MementumTrader

CMPS - Compass Pathways: Mushrooms, bro, for depressed people like myself!

dthaim

CMPS is my bet. I need to put more money into it tbh

Sledgahammer

ARQT, CMPS, DNN & URNM are straight up carrying my portfolio this year

FUWS

These unknown cannabis and mdma companies are here to create bag holders so they can RS or dilute. No thanks. TCNNF, GTBIF or CMPS as a better choice for those sectors.

Caramel-Milk42

I am 22M and just started my professional career. I have been investing since I was around 18 and made some dumb mistakes which you will see along the way particularly not investing in ETFs. Let me know where you would adjust as I continue to add to my ROTH IRA and ROTH 401K. ROTH IRA: Around 14k BND - 1.93% (starting to add here) BNDX - 2.16% (also started to add here) DOCN - 6.41% (my mistake) CMPS - 6.82% (my mistake) VXUS - 7.41% SCHD - 10.66% QQQ - 18.1% VOO - 46.7% ROTH 401k: Almost 2k Fidelity Blend 2050 - 71.62% Fidelity Blend 2060 - 28.3% (adding here in the future because this is one ill be 59) Any advice would be appreciated. First generation graduate and don't have much guidance here other than own research and stuff.

AeonDisc

Nice username. $CMPS and $ATAI are probably the best public companies right now.

dvdmovie1

CMPS does have IP (https://www.vice.com/en/article/93wmxv/can-a-company-patent-the-basic-components-of-psychedelic-therapy) but even that has cratered. Weed may see another big bounce if it's descheduled but beyond that people keep wanting it to be this great long term investment that it simply won't be - there isn't a moat, it's a commodity product and brands really don't matter nearly as much as people think. Look at Canada, where continued overproduction has been an issue since legalization: oversupply drives down prices and nothing else matters. I'm very, very pro weed but as much as I'd like there to be there isn't a compelling medium/long-term investment in it.

itssampson

CMPS.

smithxrez

CMPS. Got in at 7.96 but I think still not too late to enter.

dweiss1361

Hope so. Bagging with you on CMPS.

lipmanz

Just read that 2024 is the year of psychedelics, am I finally going to be rewarded as a CMPS baggie

purplecatfishbettie

psylocybin could be big... [https://finance.yahoo.com/quote/CMPS?p=CMPS](https://finance.yahoo.com/quote/CMPS?p=CMPS) " COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom. "

No_Cantaloupe8848

CMPS-Phase 3 clinical trials come out next year

moneymonster420

**My Prediction for DEA (timeline and next steps)** For those saying Schedule 3 would not open up capital markets immediately - you are wrong. I think it happens shortly after within weeks, with $TSND and $CURLF (who will have the TSX structure) going first and everyone else following weeks later due to more paperwork. **I think if we get DEA in December 2023, uplisting to NYSE/NASDAQ in Q1 2024 happens for sure.** Either way once we get the DEA announcement, the market will **start to price in uplisting to some extent and stock prices will move higher in anticipation of next steps (uplisting / 280e tax removal / strategics entering the space etc)**. RE: 2017-2018 whenever a Canadian LP got uplisting approval, we saw prices surge in before the uplisitng date. Kinda like what we are seeing with $BTC right now ahead of their ETF approval supposed to happen in January 2024. [https://twitter.com/Curaleaf\_IR/status/1722739106491379783](https://twitter.com/Curaleaf_IR/status/1722739106491379783) \^FYI - I expect **$CURLF TSX uplisting announcement** sometime next week or so with officially TSX shares officially trading **2 days later**. This was the case with $TSND. Kim Rivers and Boris Jordan already stated on Twitter spaces on multiple podcasts that they have been in talks with NYSE/NASDAQ for months and **$VRNOF CEO recently said their CBOE Canada listing will also make the transition happen fast.** Custody issue will be solved overnight along with the "**Cole Memo**" which would provide FINCEN and FINRA guidance. This will all be coordinated by the Biden administration. By the way - Psychedelics stocks $MNMD $ATAI $CMPS $CYBN etc are Schedule 3 and trade on the NYSE/NASDAQ 

moneymonster420

For those saying Schedule 3 would not open up capital markets immediately - you are wrong. I think it happens shortly after within weeks, with $TSND and $CURLF who will have the TSX structure going first and everyone else following weeks later. **If we get DEA in December 2023, uplisting happens to NYSE/NASDAQ in Q1 2024 for sure.** Kim Rivers and Boris Jordan already have been in talks with NYSE/NASDAQ for months and $VRNOF CEO says their COEB Canada listing will also make the transition fast. Custody issue will be solve overnight along with the "**Cole Memo**" which would provide FINCEN and FINRA guidance. **Custody issues would also be solved.** By the way - Psychedelics stocks $MNMD $ATAI $CMPS $CYBN etc are Schedule 3 and trade on the NYSE/NASDAQ. 

XcentristradicalX

CMPS

Mindmed2022

How about MNMD and CMPS? Psychedelic Market seems to have promise

Cptjoe732

CMPS - shrooms are the future

No_Cantaloupe8848

CMPS

No_Cantaloupe8848

CMPS

DC8008008

you said "at their peak", so my 90% stands. CMPS and AWAKN are down more than 90% off their all time highs, as are many others.

lifesabeach2000

CMPS asshole

Skinnybonesdavis

Speculation of course but CMPS, BETR and NUMI could have some big moves once the sector gets a boost

Any-Grapefruit-937

Compass Pathways, CMPS. They are in the later stages of Phase 2 trials of their patented psilocybin formula (technically, it is a synthetic, not actual shrooms). I bought a small amount (the stock, not the drug) about two years ago. I'm -50%. They are one of the larger players in the space. Having a proprietary product may give them an edge if it ever gets a green light. I think you should be prepared to hold for 5 years. The FDA is slow.

Jalabel_810

Believe me, forget about Mindmed, Cybin, ATAI, etc.. They're all running out of cash soon and will need finance and/or secondary offerings with strong dilutions. If you want to play Psychedelics CMPS is the one.

SearchingTudor

Compass Pathways stock ticker is CMPS, not CPTH.

leave_society

I’m buying a lot of oversold, volatile biotech stocks $ATAI $CMPS $CYBN long holds. Believe heavily the gov. will dose us all with psychedelics to make up for how fucking idiotic everything is since 2020

No_Cantaloupe8848

CMPS- reporting phase 3 results mid 2024. If you have the stomach to hold for a while, this might be a play!

Marketspike

$488 Million market cap in CMPS. Psychedelics have a long row to hoe. But as more and more data comes out in the various clinical trials. CYBN has obviously attracted the attention of Steve Cohen. The nanocaps like $SILO could really do well--IF they can get an IND in to the FDA.

AeonDisc

$CMPS Compass Pathways - psychedelic medicine is the future

toplesspete

It’s not a penny stock but look into Compass Pathways CMPS. Peter Thiel is a major backer. 1)They have a patented synthetic psilocybin, that held up in patent court. It’s legally hazy but may give them exclusivity in non-natural psilocybin. 2) They were granted special fast track clearance for important drugs by the FDA and are in Phase 3 testing for FDA approval for drug resistant depression. Phase 3 is the final stage before applying for approval. Also have other testing in various Phases for various anxiety and depression related disorders. 3) Recently they secured debt financing so look to be liquid, at least to finish up Phase 3 and present results. (FWIW having a long enough runway was personally my biggest question mark about them)

t1mmen

Re: dilution.. well, yeah. That’s the biotech sector as a whole, no? There is no (notable) income streams until the drug is FDA approved and can be prescribed/used in treatment. This company and subsector is betting on psychedelics working better than existing drugs/treatments. Their patentable psilocybin is in phase 3, estimated to be done Oct 2024: https://classic.clinicaltrials.gov/ct2/show/NCT05624268 Where are you getting 2-5 years from? For the record, I put CMPS here because no other stock in the sector can be mentioned. I’m a true believer in the compounds, but I’m certainly not putting all my eggs in one basket.

ContactHazard

Only looked at CMPS but no one is jumping on this because they’re funding operations by massively diluting shareholders. They have agreements with their lenders for warrants, convertible shares and the sale of ADs on top of employee share based comp. High/rising interest rate environment where you’re burning through money to finish your clinical trials which are 2-5 years out, if they run low on cash they will continue to issue shares. They have the benefit of no major debt maturing until 2025 but it doesn’t change their yoy funding issues.

No_Cantaloupe8848

CMPS

t1mmen

CMPS, and a few others in the psychedelic sector that I believe the rules don’t allow to be posted. Our collective and individual minds are broken, and psychedelics are showing incredible efficacy in healing us. CMPS is the furthest along for psilocybin, in Phase 3 atm for treatment resistant depression. Several others in Phase 2 for the other substances, LSD, ibogaine, etc, and novel/2nd gen versions (aka patentable) MAPS is paving the way with MDMA. FDA approval is likely happening in 2024, as their Phase 3 showed ~70% of participants cured from PTSD. Yes, cured, as in “no longer qualified for a PTSD diagnosis”. See https://www.nature.com/articles/d41586-023-02886-x Psychedelic sector has taken a hefty beating since it blew up, but at least a handful of companies have the funds to get to market with their drugs without raising further. Excellent prices for entry, and as much as biotech is binary, this is as close as a sure thing you’ll find in this sector (according to me, some idiot on the internet that you should not take financial advise from) Still… tell me I’m wrong.

Grouchy_Government23

Buying $100 of CMPS. Not educated enough to play options. Hoping it has big upside. Only playing around with $150 cash so it’s a big buy for me %age wise

i29gtaylor

Sure they can. Cheap stocks right now. Look at PSIL for diversified protection, CYBN, MNMD, CMPS & ATAI are good individual names

Grouchy_Government23

Is anyone’s interest peaked by the news about psychadelics being legalized in Oregon? Some mental health companies are testing non-treatable PTSD patients like super Mario 🍄 and CMPS secured $250M+ in funding for next phase trials. 👀

Grouchy_Government23

Why not put it all in CMPS? Trading at 9.41/share and 12-month valued low 21, high 120 average in the 40s. They just secured $250,000,000+ funding for continued PTSD trials with psychedelics that looked promising and Oregon just made shrooms legal. YOLO. I put 2/3 of my funds on it now I’m waiting to hit 2x 🤷‍♂️. I’d like to try some options trading if I can grow my chump change first. Basically using play money trading stocks as a hobby

AeonDisc

$CMPS Compass Pathways. They have IP around a synthetic Polymorph of Psilocybin (the active prodrug in "magic mushrooms") which they have defended in court 3 times already. Just secured another $185m in funding which should take them through Phase 3 by 2027.

Rav_3d

Chart analysis is not really a thing, here, though if it were, I would also point out various other bearish looking things. Since OP is looking for speculative plays, charts are secondary, since these kinds of plays are essentially lottery tickets. I hold several including IONQ, CMPS — companies leading an industry that has potential to explode some day, but not yet. In my opinion MBLY does not fall into this camp. They are an established company with negative earnings and declining revenues. There are smaller companies in the industry like VRRM (also a terrible chart) that could be acquired, but nothing about MBLY to me currently stands out as a potential future winner.

Stunning-Chance-2432

CMPS

jhonkas

CMPS

jhonkas

$CMPS

Lusitanix

Compass (CMPS)

T1-5K

CMPS - shrooms anyone? ~300M offering and price goes up!

cLearzera

In recent years, psychedelic drugs have become more common in pipelines trying to develop treatment for crippling mental health conditions. I looked for companies developing treatments for MDD, SAD, PPD, and GAD. Some like $ATAI or $CMPS use shrooms, but ketamine has shown very promising effects in treating depression, especially treatment-resistant depression. I found $SEEL and $VTGN just searching for assets under proprietary formulation of ketamine. $SEEL uses a racemic ketamine while $VTGN is of the pherine family, so same receptor. They were both large gambles, so unfortunately I ended up only going with one

moneymonster420

Psychedlics will be big too - agreed. $ATAI $CMPS Right now Cannabis will get all the hype.

TypicalDependent1067

Which ones? CMPS?

PDubsinTF-NEW

Good morning, I wanted to put this out because it hasn't popped up here yet. The FDA released a statement related to psychedelic compounds for medicinal use. [https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs](https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs) DISCLAIMER: First, I must disclose that I have positions in several of the companies mentioned in this post. Second, This is not financial advice. Now let's continue.... The press release focused on announcing a public comment period to invite study sponsors to discuss studying these compounds in clinical trials. [https://www.fda.gov/regulatory-information/search-fda-guidance-documents/psychedelic-drugs-considerations-clinical-investigations](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/psychedelic-drugs-considerations-clinical-investigations) Here are some initial thoughts on what this **COULD** mean for the industry. 1. Boost for Companies Already in Psychedelic Medicine: Companies currently researching and developing psychedelic drugs or holding patents ($HUGE, $SEEL, $CMND, $MNMD, $CMPS, $CYBN, $ATAI, $AWKNF, $CRLBF), could see their stock prices rise. This is because the guidance provides more clarity on navigating the path to potential approval, reducing regulatory uncertainties. Also, the clear recognition and support by the FDA for the potential therapeutic use of psychedelics can boost the general market's confidence in these companies. 2. Attract New Investment: The news could attract investment into this emerging sector. The guidance from the FDA signals a more accepting regulatory environment for psychedelic drugs, which could encourage venture capitalists, biotech, and pharmaceutical companies to invest more heavily in the sector. 3. A Positive Impact on the Biotech and Pharma Sector: Even for companies not directly involved in psychedelic research, this development could positively impact the broader biotech and pharmaceutical sectors. This is because the FDA's stance may indicate a willingness to consider novel treatment paradigms and be more flexible regarding drug development and approval processes. 4. A Mixed Impact on Mental Health Treatment Companies: For companies offering traditional treatments for disorders like depression, anxiety, PTSD, and substance abuse, the impact could be mixed. On the one hand, these companies might face increased competition if psychedelic treatments prove effective and are approved. On the other hand, they might see new opportunities to diversify their treatment portfolios by incorporating psychedelic medicines. 5. Enhanced Risk Consideration: The stock market always incorporates risk considerations, and this news is no different. While the FDA guidance is undoubtedly positive for the sector, psychedelic drugs are still largely in the investigational stages. There is a long road to approval, with no guarantee of success. Trials can fail, or drugs could be found to have severe side effects that limit their applicability. 6. Regulatory Sector Impact: Companies providing regulatory consulting services to pharmaceutical companies may see an increase in demand for their services, as these new guidelines will likely lead to a surge in the need for expertise in navigating the psychedelic regulatory landscape. TLDR; The FDA's new guide on how to test psychedelic drugs could cause stocks of companies making these drugs to go up because it shows the government is more open to these types of treatments. However, it's still a risky area because these drugs are still being studied and we don't know everything about them yet. What do you guys think? Is it still months or years away? Is this a false dawn like the rumor of federal cannabis decriminalization?

Any-Grapefruit-937

I have a handful of CMPS shares. I was disappointed there wasn't a sustained jump when their patent rights were upheld.

LeLoupDeWallStreet

I am HEAVILY invested in the therapeutic psychadelics space ($ATAI, $CMPS, $NUMI, $SEEL, $CYBN, $PSIL, etc.). There's a lot of blockers before anything really gets going but there are several drugs/compounds in late phase trials and prior research/studies have all the science there. People are only getting more angrier/sadder/more stressed and if these companies can find a way to treat/cure depression, PTSD, addiction, etc., I'm all about supporting it. In this for the long haul (and down significantly from the hype a couple years back). I've kept averaging down and at these point I either lose everything in these or get rich.

Which_Trust_8107

CMPS and MNMD don’t manufacture MDMA.

Difer22321

your good dude. I will take a shot at your question. I think your looking for either CMPS or MNMD as they manufacturer mdma. LSDI is also trying to get into the mdma market I think. Hopefully that helps!

MissMyPippa-2020

Pre 1$ definitely much smarter.. luv how all y’all think things out & look b4 you leap-way outta the $ @ 1.50~I know some1 who went CAN version CMPS in 20 (ran2 50$)when I got US 5$ version THAT 1’s $8ish now~mine $3….SO I AGREE w/the TREAD VERY CAREFULLY approach..LSDI better name, but I’d think the Extasy,Inogane & DMT 1’s would get more play as not done2death already I got into trading STRICTLY cuz of pot industry promises & was done WELL b4 it started!! ALL but DEAD ever since-hope2C sim of tlry@125$ again 1day but w/cure 4 cancer bioT’s flooding market,it seems only EPIC (cure4depression that doesnt have suicidal tendencies as side effect,or contact w/higher dimensional beings,ala DMT claim)would have 2 take place for REAL profitability..& they’re def out there, just beware the ever more ingenious cartel & Triad work arounds.. 🤔😳🤷🏻‍♀️(Iidk about cartels really but China has been ‘in the game’.for CENTURIES… it’s @ least possible, it’s it? LEGAL angle @ billion $ market cap co w/o all those pesky customs officers breaking your decorative vases, No Way! I’m the 1st 1 to think on it..)

PAlove

CMPS - Compass Pathways

Ecstatic-Passage-113

A lot of their studies and testing are fundamentally flawed.. Also, they're marketing towards "drug resistant" cases and the number of people impacted is pretty small. CMPS is probably your best bet in this space. Im bag holding them and MNMD.

Gigglemind

!banbet CMPS + 3.0% 2d

heliumbox

Threw my sad remaining CMPS position into MSOX day after announcement assuming it'll outperform CMPS and make up some losses quicker.

JMSeaTown

$CMPS is my favorite and they’re healing a lot of PTSD patients

Adventurous-Earth328

I'm with you up until the PSIL ETF recommendation. That thing seems so poorly structured. The two main players in it are Compass CMPS and Cybin CYBN, even on days they've both traded up, PSIL still trades down. I have yet to see anything good come from PSIL. That said, your knowledge on the history and science on psychedelics is spot on!

aboriginalgrade

FDA has given fast track designation to compass pathways (CMPS) for their psilocibin treatment of TRD, which is in phase 3 right now. So the FDA is clearly in support of it. CMPS has also gotten a similar designation in Europe, so their success isnt just limited to US politics. If the FDA approves the therapy, the DEA has a certain number of days to reschedule by law, so the FDA has a lot of power here. Ketamine is already used for TRD, so I believe they have already tested the waters on the use of drugs that have controversial recreational use outside of the clinic. Finally, the use of psychedelics for the treatment of veterans with PTSD has gained a lot of political attention lately (a bipartisan caucus is being formed to explore this), so overall the movement has momentum behind it, which helps derisk regulatory concerns in my opinion. CMPS also has PTSD in phase 2

babywhiz

I got a few….lessee…CMPS. BIOL.NBEV.

Head_Cardiologist434

Loading up on CMPS. 33.8% short float. 🤡

flatech

>CMPS What made you want to invest in that in the first place?

sunfacethedestroyer

Yeah, i'm 5% away from being able to unload CMPS. All I ask is for a few more days of rally, then we can start drilling again.

pro1024

MNMD, SEEL, CMPS are a few

ybnesman

Unrelated but im eyeballing the fuck out of ATAI and CMPS. ATAI was listed at $20 and its 1.27 now. A lot of research and money going into psychedelics for therapy and Covid and smartphones have done a number on the younger generation. Regulations is a problem but all the research points towards them working vastly better than the methods in place now.

GypsyPhoto

Yes just hold, KMTUY/CMPS I have no idea on.

LowSleep2566

Was asking on the general consensus- not necessarily Individual advice- but for what it's worth: Mostly domestic, need to mix it up more CHD CAT WM CL WHR KHC SMG MSFT T SONY KMTUY CMPS O VOO

natures3

Calls on $CMPS

InerasableStain

Just need to find something cheaper that you can afford 100 of. I started with CMPS, and actually liked the company. I didn’t make a ton of money with it, but have almost made the cost of the 100 at which point it’s paid for itself

DadaPope

I need MULN, CMPS and MNMD to go up like 700% can we do it

StockSwingWatcher

1. $AVRO - Bio company with 4 catalysts coming up this month per [biopharmcatalyst.com](https://biopharmcatalyst.com) 2. $SI - Big believer in the squeeze, recent purchases, crypto gaining, and undervalued from it's drop off 3. $CYBN/$CMPS - Long term a big supporter of psychedelic stocks and CYBN has catalysts this month for drug trials

Few-Dig7870

I haven’t heard/looked much into them, but I’ll keep an eye out. I have been buying PSIL which is an ETF completely invested in psychedelic companies like CYBN, CMPS, MNMD and a few others valued around 2.30$ which if these catalysts come to fruition this etf can easily be worth 30-40$+ in the future and I’m sure if CMND makes some plays in the market this ETF will add them to their portfolio

kyleperk97

Yeah there are many catalysts that could shoot $CYBN $CMPS and others up. Any thoughts on $CMND? A new psychedelic company in Israel that just filled new patents

kittenswinger8008

If you're actually interested, my pharma guy (UK, not allowed to trade pharma stocks as an ambassador) recommended CMPS for a cheeky little gamble. They already havethe active chemicals synthesised, so no worries about growing, and are the main company that provides the psilocybin for research. So if mushrooms are legalised for mental health, he reckons they're the ship to be on

Critical_Land5085

CMPS